Title : The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer.

Pub. Date : 2022

PMID : 35198079






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Notably, the PPAR-gamma agonist rosiglitazone reversed the metastatic properties of FABP4-deficient GC cells in vitro and demonstrated viable therapeutic potential in multiple mouse models. Rosiglitazone peroxisome proliferator activated receptor gamma Mus musculus